HOLD
₹1,964
₹1,854
₹2,242
14.15%
In its 17 August 2026 analyst-meet update on Colgate Palmolive, Prabhudas Lilladher retained its HOLD recommendation with an unchanged target price of Rs2,242. The current market price was Rs1,964. The broker described the outlook as steady, with growth supported by premium oral-care brands, improving urban demand, and the growing contribution of e-commerce and quick commerce.
However, Prabhudas Lilladher considers the growth rate uninspiring and expects elevated advertising and promotion expenditure to constrain meaningful margin expansion.
Management’s core strategy is to use technology, consumer experience and physical availability to grow the toothpaste business. Colgate Strong Teeth is supported by arginine technology and is clinically proven to offer better cavity prevention and remineralisation versus the number-two player. MaxFresh and Active Salt have also received formula upgrades, while packaging across the portfolio has been upgraded to strengthen premium perception and shelf visibility.
Premiumisation is a central growth driver. Colgate Total, Visible White and PerioGard are the three priority premium brands, and premium toothpaste is growing at about six times the rate of the core business. Management sees further runway because products priced above 140 per cent of the category index account for only about 19 per cent of toothpaste sales.
Colgate has launched packs priced below Rs100 for Total and Visible White to widen access and general-trade distribution. Harry Potter-themed toothpaste and toothbrushes, along with a new toothpaste pump format, are being rolled out. Advertising spend for the premium category is above 50 per cent and is likely to remain high in the medium term.
Colgate Sensitive remains a challenger to Sensodyne in the fast-growing sensitivity segment. Management indicated that Colgate Sensitive has grown about 10 times faster than the sensitivity category since January, albeit from a small base. A key competitive risk is Sensodyne’s entry into whitening, where Colgate Visible White has a strong position.
E-commerce is already in the early double digits as a share of Colgate Palmolive’s business, ahead of the roughly 6 per cent industry contribution. Management considers e-commerce more profitable, with margins about 400 basis points above the company average, and views quick commerce as particularly attractive for premium products and innovative stock-keeping units.
E-commerce also serves as a discovery platform from which successful products can be scaled through modern trade. Premiumisation is strongest in quick commerce, followed by e-commerce, modern trade and general trade, with traction extending beyond metros into Tier-2, Tier-3 and rural markets. Modern trade plus e-commerce and quick commerce has increased from 16 per cent to 20 per cent of sales over the past three years.
Oral-care penetration offers a longer-term volume opportunity despite 100 per cent toothpaste penetration in urban and rural markets. Oral care reaches only 56 per cent of FMCG outlets, while Colgate Palmolive’s direct and indirect reach is 7.1 million outlets.
The broker highlighted scope to lift twice-daily brushing penetration, currently 24 per cent, and increase daily brushing in rural India. The proportion of urban consumers not brushing twice daily has declined from about 80 per cent to 76 per cent, while rural consumers not brushing daily have reduced from about 55 per cent to 45 per cent.
Management acknowledged disappointing Palmolive performance, although premium hand wash showed early signs of progress. Bombay Shaving Company will handle Palmolive’s consumer-facing e-commerce and direct-to-consumer media and brand management. Colgate Palmolive will retain responsibility for innovation, quality, supply chain, traditional trade, modern trade and traditional advertising.
Management expects the turnaround to take time given the weak base.
Prabhudas Lilladher forecasts mid-single-digit volume growth, a 9.0 per cent EPS CAGR over FY26-FY28, and double-digit PAT growth for much of FY27 on a low base. Its FY27E and FY28E estimates are unchanged:
| Financial metric | FY27E | FY28E |
|---|---|---|
| Sales | Rs66,541 million | Rs71,931 million |
| EBITDA | Rs20,593 million | Rs22,525 million |
| EPS | Rs54.2 | Rs59.0 |
The broker values Colgate Palmolive at 38 times March 2028 EPS to derive its Rs2,242 target price. It considers the stock inexpensive at about 33 times FY28 earnings.
Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.
Copyright 2026 by DSIJ Wealth Advisory Pvt. Ltd. (Formerly Known as DSIJ Pvt. Ltd.)